CVE-2025-43825A vulnerability in Liferay Portal 7.4.0 through 7.4.3.132, and Liferay DXP 2025.Q1.0 through 2025.Q1.4, 2024.Q4.0 through 2024.Q4.5, 2024.Q3.0 through 2024.Q3.13, 2024.Q2.1 through 2024.Q2.13, 2024.Q…
Updated under an hour ago ()
Does this affect you?
It affects Liferay Portal and 3 other products. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
A vulnerability in Liferay Portal 7.4.0 through 7.4.3.132, and Liferay DXP 2025.Q1.0 through 2025.Q1.4, 2024.Q4.0 through 2024.Q4.5, 2024.Q3.0 through 2024.Q3.13, 2024.Q2.1 through 2024.Q2.13, 2024.Q1.1 through 2024.Q1.12, 2023.Q4.0 through 2023.Q4.10, 2023.Q3.1 through 2023.Q3.10, and 7.4 GA through update 92 allows sensitive user data to be included in the Freemarker template. This weakness permits an unauthorized actor to gain access to, and potentially render, confidential information that should remain restricted.
- CVSS
- 4.6 MEDIUM (v4.0, CNA)CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:A/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N
- Weakness (CWE)
- CWE-201
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Liferay
- NVD analysis
- Analyzed
- Record last updated
- Oct 6, 2025
- First seen by InfoSec Signals
- Oct 18, 2026
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.